The importance of SCN1A gene mutation screening in severe epilepsy syndromes, such as Dravet syndrome is well established, however, the role of SCN1A variations in other phenotypes is not fully understood4–10. This evidence concerns the gene SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.